A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: inside layer (24), coating (68), liner (5)

Vinflunine

Description
Chemotherapy Protocol BLADDER Regimen VINFLUNINE • Bladder – Vinflunine Indication • Bladder cancer that has failed to respond or progressed with in twelve months
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Vinflunine.pdf

Cisplatin (35) Gemcitabine ver1.1

Description
Chemotherapy Protocol BLADDER CISPLATIN (35)-GEMCITABINE Regimen Bladder-Cisplatin (35)-Gemcitabine Indication For use in patients unable to tolerate standard cisplatin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Cisplatin-35-Gemcitabine-ver1.1.pdf

Atezolizumab

Description
Chemotherapy Protocol GENITOURINARY CANCER Atezolizumab Regimen • Bladder – Atezolizumab Indication • The treatment of adult patients with locally advanced or metastatic urothelial carcinoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab.pdf

Ibrutinib (MCL) (560mg)

Description
Chemotherapy Protocol Mantle Cell Lymphoma Regimen Ibrutinib • MCL – Ibrutinib (560mg) Indication • Mantle Cell Lymphoma with cyclin D1 overexpression or translocation breakpoints
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Ibrutinib-MCL-560mg.pdf

FC PO (5 day)-Cyclophosphamide-Fludarabine PO 5 day Ver 1.1

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-FLUDARABINE ORAL 5 DAY (FC PO 5 day) Regimen Lymphoma – FC PO (5 day)-Cyclophosphamide-Fludarabine PO
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/FC-PO-5-day-Cyclophosphamide-Fludarabine-PO-5-day-Ver-1.1.pdf

CVP-Cyclophosphamide-Prednisolone-Vincristine Ver 1.2

Description
Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-PREDNISOLONE-VINCRISTINE (CVP) Regimen Lymphoma – CVP-Cyclophosphamide-Prednisolone-Vincristine Indication Non Hodgkin’s Lymphoma Toxicity Drug Adverse
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/CVP-Cyclophosphamide-Prednisolone-Vincristine-Ver-1.2.pdf

InP-PAM-(cycles 5-6) v1

Description
Chemotherapy Protocol Sarcoma DOXORUBICIN-METHOTREXATE (cycles 5-6) Inpatient Regimen There are multiple versions of this protocol in use. Please ensure
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InP-PAM-cycles-5-6-v1.pdf

InPEtoposideIfosfamide(5dy)Ver1

Description
Chemotherapy Protocol SARCOMA ETOPOSIDE-IFOSFAMIDE (5 day) Inpatient Regimen Regimen Sarcoma-InP-Etoposide-Ifosfamide (5 day) Indication Second line treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPEtoposideIfosfamide5dyVer1.pdf

InP Ifosfamide(2day)Ver1

Description
Chemotherapy Protocol SARCOMA IFOSFAMIDE (2 day) Inpatient Regimen Regimen Sarcoma-InP-Ifosfamide (2 day) Indication Advanced or metastatic soft tissue sarcoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPIfosfamide2dayVer1.pdf

InP DoxorubicinIfosfamideVer1

Description
Chemotherapy Protocol SARCOMA DOXORUBICIN-IFOSFAMIDE In-Patient Regimen Regimen Sarcoma – InP-Doxorubicin - Ifosfamide Indication Soft tissue sarcoma WHO performance status 0
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/InPDoxorubicinIfosfamideVer1.pdf
561 to 570 of 743
Previous … 55 56 57 58 59 … Next